Cutting-edge therapies, sophisticated
diagnostics, and clinical trials at a convenient location near you.
We’re here for you. Call us at 844-346-7222 or
Fighting cancer is hard no matter what, but that fight can be even harder when you have to travel to a major city for care. That’s why RCCA has brought the latest in treatment for cancer and blood disorders to your community, where our oncology and hematology specialists know and practice alongside your other doctors, and take the time needed to know you, to develop a highly individualized treatment plan for you, and to address all your questions and concerns.
With 20+ locations throughout New Jersey, Connecticut, Maryland, and the Washington, DC area, our cancer and blood disorder specialists offer world-class care close to home, so that you can focus on the most important thing in the world – your health.
Our 80+ cancer and blood disorder specialists have deep expertise and long experience in treating every type of cancer and blood disorder, from the common to the rare, and including both solid tumors and blood-based malignancies.
At RCCA, we don’t treat diagnoses or conditions, we treat people. And everyone at an RCCA care center – from our board-certified medical oncologists/hematologists and expert nurses to our lab technicians and receptionists — treats our patients and their families the way we would want to be treated if we were facing cancer or a blood disorder.
That’s our commitment to you — and that’s why more than 250,000 people each year trust us to provide transformative care that transforms their lives for the better.
If your physician has prescribed an infused medication for you, you’re in good company.
Compassion, skill, collaboration, leadership, knowledge. These are just a few of the things that set some physicians apart from the rest, and they are qualities commonly found in those at the forefront of their field.
Offering patients the latest in cutting-edge treatments, including immunotherapies and targeted therapy, as well as access to a wide range of clinical trials, the Moorestown office of Regional Cancer Care Associates (RCCA) salutes the five members of its staff recently named to South Jersey Magazine’s list of Top Physicians for Women in 2022 – Hematology/Oncology.
Black Americans with lung cancer are 18% less likely than white people to be diagnosed in the early stages of the disease, 23% less likely to receive surgery, and 21% less likely to survive 5 years after diagnosis, according to the American Lung Association.
